Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 3Skin Diseases 2Neoplasms by Site 2Carcinoma, Renal Cell 2Uveal Melanoma 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasm Metastasis 1Kidney Neoplasms 1Hematologic Diseases 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Female Urogenital Diseases and Pregnancy Complications 1Communicable Diseases 1Breast Neoplasms 1Breast Diseases 1Autoimmune Diseases 1

Interventions

binimetinib 2Watchful Waiting 2Aminolevulinic Acid 2palbociclib 1ipatasertib 1exemestane 1encorafenib 1baricitinib 1atezolizumab 1Vemurafenib 1VP-102 1Trabectedin 1Paclitaxel 1Injections, Intradermal 1Gonadotropin-Releasing Hormone 1Everolimus 1Dacarbazine 1Cantharidin 1BF-200 ALA 1Anastrozole 1AZD9833 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Skin Diseases × Watchful Waiting × Clear all
NCT05080907 2022-11-09

Collection and Distribution of Biospecimens for Novel Research

iSpecimen Inc

Unknown
100,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT04016935 2022-05-17

EndoPredict® Extended Endocrine Trial (EXET)

Myriad Genetic Laboratories, Inc.

Terminated
855 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡